World Menopause Day

In 1999, a scientific society founded in Switzerland and the World Health Organization put their names to a joint declaration that gave menopause, a biological transition every woman who lives long enough will experience, its own fixed date on the global health calendar for the first time.
Introduction
World Menopause Day falls on 18 October each year, established through the joint efforts of the International Menopause Society and the World Health Organization to raise awareness of menopause and the health support available to women going through it. The day exists partly as a corrective: menopause research and clinical guidance lagged for decades behind other areas of women’s health, and the observance was designed to give the topic a recurring, predictable place in public health calendars and medical journals rather than leaving it to occasional press coverage.
Origin
The International Menopause Society, founded in 1978 as a scientific body bringing together researchers and clinicians studying the menopausal transition, worked with the World Health Organization through the late 1990s to formalise a joint declaration recognising the need for greater public and clinical attention to menopause-related health. That declaration led directly to the first World Menopause Day, observed on 18 October 2000, chosen to sit within World Menopause Month, a broader October awareness period the society had already been building support for among its national affiliate societies across dozens of countries. The specific date carries no symbolic significance beyond its placement within that wider October campaign window, a detail the society has stated plainly rather than attaching an invented origin story to the choice.
History
Menopause research as a distinct clinical field is younger than many people assume. Although the biological transition itself is as old as human female reproductive biology, systematic medical study of it did not really begin until the mid-20th century, and for much of that period research focused narrowly on hormone replacement therapy rather than on the fuller range of physical and psychological symptoms women reported. The International Menopause Society’s founding in 1978 coincided with growing clinical interest in oestrogen therapy, which had been introduced commercially in the United States decades earlier but remained poorly understood in terms of long-term risk. That picture shifted dramatically in 2002, when the US Women’s Health Initiative study, a large randomised trial, published findings linking certain hormone therapy regimens to increased risks of breast cancer and cardiovascular events, triggering a sharp global decline in hormone therapy prescriptions that took the better part of two decades to partially reverse as later, more nuanced re-analyses of the data emerged. World Menopause Day’s messaging in the years following 2002 shifted accordingly, moving toward more individualised guidance on treatment risk and benefit rather than blanket recommendations either for or against hormone therapy, a recalibration the society has continued refining as new research on formulation, timing and dosage has been published.
Importance
Menopause affects roughly half the global population at some point in life, yet awareness campaigns built around the day consistently cite research showing that many women receive little formal medical guidance about what to expect, often piecing together information informally from friends or online forums rather than clinicians. The transition carries measurable health implications beyond its more commonly discussed symptoms; declining oestrogen levels are linked to increased cardiovascular risk, a connection that ties menopause awareness directly to campaigns like World Heart Day, and to reduced bone density that raises osteoporosis risk in the years following the transition. Workplace awareness has become a growing theme of the day’s advocacy in recent years, with several countries seeing new employer guidance on menopause-related workplace accommodations only in the past decade, decades after the day itself was first established.
How It’s Celebrated
National menopause societies, most affiliated with the International Menopause Society’s global network, hold public information sessions and free clinics offering guidance on symptom management and treatment options. Media partnerships have become a significant feature of the day’s activity, with several major broadcasters in the UK and Australia running dedicated menopause health segments timed to 18 October, a practice that grew substantially after several prominent public figures began speaking openly about their own experiences in the 2010s, helping shift the topic out of what had long been a largely private conversation. Employers in a growing number of countries mark the day with internal awareness sessions and menopause policy launches, reflecting the increasing recognition that menopausal symptoms, including sleep disruption and difficulty concentrating, can affect workplace performance and retention if unsupported.
World Variations
In the United Kingdom, the day typically features NHS-backed public messaging alongside advocacy from women’s health charities pushing for menopause-specific training to become standard for general practitioners, following research suggesting many GPs received minimal formal menopause education during medical school. In Japan, cultural attitudes toward openly discussing menopause have historically been more reserved, and awareness campaigns tied to the day there have focused heavily on normalising conversation within families and workplaces rather than solely on clinical treatment options. In several Latin American countries, the International Menopause Society’s regional affiliate societies have used the day to campaign for wider public health system coverage of hormone therapy, arguing that treatment access remains concentrated among women who can afford private care.
Traditions and Symbols
The day does not have a single universally recognised colour or symbol in the way some awareness campaigns do, though purple has appeared frequently in International Menopause Society branding materials in recent years. Public campaigns increasingly favour ordinary, unposed photography of women at various life stages over clinical or overtly symbolic imagery, a stylistic shift advocates say better reflects the day’s aim of normalising menopause as an ordinary life transition rather than a medical crisis requiring dramatic visual framing.

Fun Facts
The average age of natural menopause onset across most studied populations sits around 51, though the range considered clinically normal spans roughly a decade either side of that figure. The 2002 Women’s Health Initiative study that reshaped hormone therapy prescribing was actually halted early, before its planned completion date, because the data safety monitoring board judged the risks observed were significant enough that continuing the trial as designed was no longer justified. The term “menopause” itself derives from Greek roots meaning “month” and “cessation,” and entered medical usage in France in the early 19th century before spreading into English medical literature later that century. Perimenopause, the transitional period leading up to full menopause, can last anywhere from a few months to more than a decade, a variability that awareness campaigns cite often when explaining why symptom onset timing differs so widely between individuals. Surgical menopause, brought on by procedures such as ovary removal rather than natural ageing, can occur at any age and tends to produce a more abrupt onset of symptoms than the gradual transition most women experience, a distinction clinicians say is still poorly understood among the general public. The International Menopause Society’s membership spans clinicians and researchers from more than 80 countries, making it one of the more genuinely global specialist medical societies behind any single awareness day. Some of the earliest documented medical writing on menopause dates to ancient Greek physicians, who noted the cessation of menstruation as a life-stage marker centuries before any understanding of its hormonal basis existed. The Women’s Health Initiative trial that reshaped hormone therapy guidance in 2002 followed more than 16,000 women and remains, decades later, one of the largest randomised studies ever conducted on women’s health specifically, a scale rarely matched in research covering a condition affecting half the population.
Physical and Psychological Symptoms
Menopause campaigns tied to 18 October increasingly emphasise the full range of symptoms beyond the hot flushes most commonly associated with the transition in popular understanding. Sleep disruption, joint pain, changes in mood, and difficulty with memory and concentration, sometimes referred to informally as “brain fog,” are all recognised by the International Menopause Society as legitimate symptoms warranting clinical attention rather than something women should simply endure. Vaginal and urinary symptoms linked to declining oestrogen, grouped clinically under the term genitourinary syndrome of menopause, receive particular attention in the society’s day-of messaging, since research has repeatedly found these symptoms are under-reported by patients and under-asked-about by clinicians, leaving a treatable condition frequently unaddressed for years. The broader connection between menopause and long-term health, including its relevance to campaigns such as International Day of Women’s Health, has become a more prominent theme in recent years as researchers have pushed back against treating menopause purely as a set of short-term symptoms rather than a transition with decades-long implications for cardiovascular and bone health.
Treatment Evolution Since 2002
The years following the 2002 Women’s Health Initiative findings saw hormone therapy prescriptions fall sharply across most Western countries, a decline that public health researchers have since argued left many women without effective treatment for genuinely disruptive symptoms during a period when the risks reported in the original study were later found to apply mainly to older women starting therapy many years after menopause onset, rather than to the broader population. Re-analyses published over the following two decades, alongside newer trial data specifically examining younger women closer to menopause onset, gradually built a more nuanced risk picture, and International Menopause Society guidance updated accordingly, now emphasising individualised assessment of timing, formulation and personal risk factors rather than the broad caution that dominated clinical practice through much of the 2000s and 2010s. Non-hormonal treatment options have also expanded significantly in the same period, giving clinicians more tools for patients who cannot or prefer not to use hormone therapy, a shift the day’s clinical programming highlights alongside its awareness activity, including its ties to broader campaigns on sexual and reproductive health.
A Closing Reflection
A transition experienced by roughly half of humanity took until 1999 to receive a coordinated global health declaration, and the two and a half decades since have been less about discovering new biology than about finally building the clinical infrastructure, and the public permission, to talk about it properly.




